Astrocytes: role and functions in brain pathologies

R Siracusa, R Fusco, S Cuzzocrea - Frontiers in Pharmacology, 2019 - frontiersin.org
Astrocytes are a population of cells with distinctive morphological and functional
characteristics that differ within specific areas of the brain. Postnatally, astrocyte progenitors …

Involvement of astrocytes in Alzheimer's disease from a neuroinflammatory and oxidative stress perspective

RE González-Reyes, MO Nava-Mesa… - Frontiers in molecular …, 2017 - frontiersin.org
Alzheimer disease (AD) is a frequent and devastating neurodegenerative disease in
humans, but still no curative treatment has been developed. Although many explicative …

Application and mechanisms of triptolide in the treatment of inflammatory diseases—a review

K Yuan, X Li, Q Lu, Q Zhu, H Jiang, T Wang… - Frontiers in …, 2019 - frontiersin.org
Bioactive compounds from medicinal plants with anti-inflammatory and immunosuppressive
effects have been emerging as important sources of drugs for the treatment of inflammatory …

Triptolide: Medicinal chemistry, chemical biology and clinical progress

W Hou, B Liu, H Xu - European journal of medicinal chemistry, 2019 - Elsevier
In the past decades, triptolide has attracted considerable interests in the organic and
medicinal chemistry society owing to its intriguing structure features and promising multiple …

Research progress of natural products and their derivatives against Alzheimer's disease

JY Liu, HY Guo, ZS Quan, QK Shen… - Journal of enzyme …, 2023 - Taylor & Francis
Abstract Alzheimer's disease (AD), a persistent neurological dysfunction, has an increasing
prevalence with the aging of the world and seriously threatens the health of the elderly …

A comparative study of the neuroprotective effects of dl-3-n-butylphthalide and edaravone dexborneol on cerebral ischemic stroke rats

H Zhang, L Wang, B Zhu, Y Yang, C Cai… - European Journal of …, 2023 - Elsevier
Abstract Introduction DL-3-n-butylphthalide (NBP) and edaravone dexborneol (Eda-Dex) are
two promising reagents for stroke treatment. However, the impacts of NBP and Eda-Dex on …

The therapeutic potential of triptolide and celastrol in neurological diseases

Y Cui, X Jiang, J Feng - Frontiers in Pharmacology, 2022 - frontiersin.org
Neurological diseases are complex diseases affecting the brain and spinal cord, with
numerous etiologies and pathogenesis not yet fully elucidated. Tripterygium wilfordii Hook …

[HTML][HTML] New insights in drug development for Alzheimer's disease based on microglia function

O Qiao, H Ji, Y Zhang, X Zhang, X Zhang, N Liu… - Biomedicine & …, 2021 - Elsevier
One of the biggest challenges in drug development for Alzheimer's disease (AD) is how to
effectively remove deposits of amyloid-beta (Aβ). Recently, the relationship between …

SIRT1 facilitates amyloid beta peptide degradation by upregulating lysosome number in primary astrocytes

MZ Li, LJ Zheng, J Shen, XY Li, Q Zhang… - Neural regeneration …, 2018 - journals.lww.com
Previous studies have shown that sirtuin 1 (SIRT1) reduces the production of neuronal
amyloid beta (Aβ) and inhibits the inflammatory response of glial cells, thereby generating a …

Triptolide-targeted delivery methods

H Xu, B Liu - European Journal of Medicinal Chemistry, 2019 - Elsevier
Triptolide, a complex triepoxide diterpene natural product, has attracted considerable
interest in the medicinal society due to its multiple biological activities. However, poor water …